Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Payables (2016 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Payables for 6 consecutive years, with $1.4 million as the latest value for Q3 2021.

  • Quarterly Payables rose 9.37% to $1.4 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2021, up 9.37% year-over-year, with the annual reading at $910183.0 for FY2020, 54.64% down from the prior year.
  • Payables for Q3 2021 was $1.4 million at ENDRA Life Sciences, down from $1.5 million in the prior quarter.
  • The five-year high for Payables was $2.0 million in Q4 2019, with the low at $132646.0 in Q2 2017.
  • Average Payables over 5 years is $1.1 million, with a median of $1.2 million recorded in 2020.
  • The sharpest move saw Payables soared 466.45% in 2018, then tumbled 54.64% in 2020.
  • Over 5 years, Payables stood at $848214.0 in 2017, then grew by 14.9% to $974583.0 in 2018, then soared by 105.89% to $2.0 million in 2019, then crashed by 54.64% to $910183.0 in 2020, then soared by 59.21% to $1.4 million in 2021.
  • According to Business Quant data, Payables over the past three periods came in at $1.4 million, $1.5 million, and $1.5 million for Q3 2021, Q2 2021, and Q1 2021 respectively.